The treatment of advanced renal cell cancer with high-dose oral thalidomide

Thalidomide is reported to suppress levels of several cytokines, angiogenic and growth factors including TNF-α, basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6). The resulting anti-angiogenic, immunomodulatory and growth suppressive effects fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Stebbing, J, Benson, C, Eisen, T, Pyle, L, Smalley, K, Bridle, H, Mak, I, Sapunar, F, Ahern, R, Gore, M E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375104/
https://www.ncbi.nlm.nih.gov/pubmed/11592764
http://dx.doi.org/10.1054/bjoc.2001.2025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375104/
https://www.ncbi.nlm.nih.gov/pubmed/11592764
http://dx.doi.org/10.1054/bjoc.2001.2025

Ejemplares similares